Pnc Financial Services Group, Inc. Actinium Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $143 Billion
- Q1 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 100 shares of ATNM stock, worth $740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$740% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ATNM
# of Institutions
72Shares Held
6.65MCall Options Held
369KPut Options Held
148K-
Black Rock Inc. New York, NY1.71MShares$12.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$10.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA596KShares$4.41 Million0.0% of portfolio
-
State Street Corp Boston, MA551KShares$4.08 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL231KShares$1.71 Million0.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $186M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...